← All trials
NCT02264535
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2014
- Primary completion
- Nov 1, 2014
- Completion date
- —
- First posted
- —
- Last posted
- —
- Enrollment
- 149
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Jiangsu Kanion Pharmaceutical Co., LtdLead sponsor
- Tianjin University of Traditional Chinese MedicineOverall official - principal investigator
- Beijing Bionovo Medicine Development Co., Ltd.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.